Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt
Scott Thomas(Memorial Hospital of South Bend), Pamela N. Münster(University of California, San Francisco)
Cited by 30
Related Papers
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
|Nature Communications|2020|342
Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression
|Breast Cancer Research|2015|95
Proceedings of resources for optimal care of acute care and emergency surgery consensus summit Donegal Ireland
|World Journal of Emergency Surgery|2017|66
Author Correction: Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancer
|Nature Communications|2020|13